Compare ILMN & DRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ILMN | DRI |
|---|---|---|
| Founded | 1998 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.7B | 25.9B |
| IPO Year | 2000 | 2000 |
| Metric | ILMN | DRI |
|---|---|---|
| Price | $202.98 | $222.54 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 17 | 25 |
| Target Price | $124.24 | ★ $226.50 |
| AVG Volume (30 Days) | ★ 1.9M | 1.1M |
| Earning Date | 04-30-2026 | 03-19-2026 |
| Dividend Yield | N/A | ★ 3.06% |
| EPS Growth | ★ 170.87 | 17.16 |
| EPS | 2.22 | ★ 10.38 |
| Revenue | $4,343,000,000.00 | ★ $13,210,900,000.00 |
| Revenue This Year | $6.47 | $10.58 |
| Revenue Next Year | $5.58 | $3.73 |
| P/E Ratio | $84.82 | ★ $21.08 |
| Revenue Growth | N/A | ★ 9.39 |
| 52 Week Low | $88.00 | $169.00 |
| 52 Week High | $207.00 | $229.76 |
| Indicator | ILMN | DRI |
|---|---|---|
| Relative Strength Index (RSI) | 60.35 | 60.96 |
| Support Level | $182.76 | $190.21 |
| Resistance Level | $207.00 | N/A |
| Average True Range (ATR) | 7.53 | 5.45 |
| MACD | -0.76 | 1.05 |
| Stochastic Oscillator | 80.62 | 71.30 |
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Darden Restaurants is the largest global full-service dining operator, with over $12 billion in system sales across 2,159 company-owned stores at the end of fiscal 2025, spanning the US and Canada. The firm operates 10 banners in four segments, including Olive Garden (43% of sales), LongHorn Steakhouse (25%), and fine dining (21%), which includes The Capital Grille, Ruth's Chris, and Eddie V's. The other 11% of sales comes from smaller concepts such as Yard House and Cheddar's. Darden primarily generates revenue through sales of food and beverage items at its company-owned restaurants. It also earns royalties on sales from 154 franchised locations in US and international markets, which sit within the other segment but are immaterial to consolidated results.